Profile Picture
Français
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Canada
  • World
  • Entertainment
  • Sci/Tech
  • Business
  • Politics
  • Sports
  • Lifestyle
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Alzheimer's, Novo Nordisk

Digest more
 · 8m
Analysis-Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer's prevention
Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still asking if GLP-1 drugs should be tested to prevent the disease in people at risk.

Continue reading

 · 1d · on MSN
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
 · 1d · on MSN
Novo Nordisk’s Ozempic Pill Fails in Long-Shot Alzheimer’s Effort
6h

What's Happening With Novo Nordisk Stock?

While Eli Lilly stock has surged beyond a $1 trillion market capitalization, Novo Nordisk is having difficulty keeping up, both in growth and pipeline progression.
1don MSN

Novo Nordisk Faces Setback. Here's What Caused the Ozempic Maker's Stock to Tumble Monday.

Novo Nordisk shares tumbled Monday morning after the Danish drugmaker posted the latest results from a drug trial.
7don MSN

Novo Nordisk to offer select doses of Ozempic, Wegovy at a steep discount

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...
8don MSN

Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic for some customers

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
  • Privacy
  • Terms